Company: HCWB
Filing Date: 2025-04-07
Form Type: S-1
Source: 0001193125-25-073723
Chunk: 13

Company: HCW Biologics Inc.
Filing Date: 2025-04-07
Form: S-1
Chunk 13
---
 the date of this prospectus. 
                                                                                       Additionally, we will not receive any proceeds from any sale of shares of our Common Stock by Armistice. However, we may receive up to $6,918,510 in aggregate 
                                                                                           gross proceeds from Armistice upon the exercise of the Purchase Warrants after the date of this prospectus. We intend to use any proceeds from the sale of 
 shares to Square Gate under the ELOC and sales of shares to Armistice under the Purchase Warrants for general corporate purposes. General corporate purposes may include funding the continued progress of our preclinical and clinical development, 
            research and development costs, manufacture and supply of product, potential strategic acquisitions or licensing of complementary businesses, services or technologies, working capital, capital expenditures and other general corporate 
                                                                                                                                                                                                                                            purposes. |
| Risk Factors                                                         |     |                                             Investing in our securities involves a high degree of risk. You should review carefully the risks and uncertainties described under the heading “Risk Factors” beginning on page [●] of this prospectus. |
| Nasdaq Symbols                                                       |     |                                                                                                                                                                                        Our Common Stock is listed on Nasdaq under the symbol “HCWB”. |

7

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS This prospectus and the information incorporated herein by reference contain forward-looking. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations, and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy, and other future conditions. This includes, without limitation, statements regarding the financial position and the plans and objectives of management for our future operations. Such statements can be identified by the fact that they do not relate strictly to historical or current facts. When used in this prospectus, words such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “strive,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements in this prospectus and in any document incorporated by reference in this prospectus, including the Annual Report filed on Form 10-Kon March 28, 2025 (the “Annual Report”), may include, for example, statements about: